Digoxin
- Product NDC
- 50564-545
- 11-digit product format
- 505640545
- Labeler code
- 50564
- Product ID
- 50564-545_a95973ec-9445-4df0-8f10-2318719ccc43
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Digoxin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Jerome Stevens Pharmaceuticals, Inc.
- Application
- ANDA076268
- Marketing category
- ANDA
- Marketing start
- 2002-07-26
- Marketing end
- 0000-00-00
- Substance
- DIGOXIN
- Active strength
- 250 ug/1
- Pharmacologic classes
- Cardiac Glycoside [EPC],Cardiac Glycosides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50564-545-01 | Digoxin | 100 in 1 BOTTLE | TABLET | 100 | | 13 |
| 50564-545-10 | Digoxin | 1000 in 1 BOTTLE | TABLET | 1000 | | 13 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| DIGOXIN | ACTIVE INGREDIENT | 73K4184T59 | DIGOXIN TABLET [JEROME STEVENS PHARMACEUTICALS, INC.] | 12 | |
| DIGOXIN | ACTIVE MOIETY | 73K4184T59 | DIGOXIN TABLET [JEROME STEVENS PHARMACEUTICALS, INC.] | 12 | |
| ALUMINUM OXIDE | INACTIVE INGREDIENT | LMI26O6933 | DIGOXIN TABLET [JEROME STEVENS PHARMACEUTICALS, INC.] | 12 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | DIGOXIN TABLET [JEROME STEVENS PHARMACEUTICALS, INC.] | 12 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | DIGOXIN TABLET [JEROME STEVENS PHARMACEUTICALS, INC.] | 12 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | DIGOXIN TABLET [JEROME STEVENS PHARMACEUTICALS, INC.] | 12 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | DIGOXIN TABLET [JEROME STEVENS PHARMACEUTICALS, INC.] | 12 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | DIGOXIN TABLET [JEROME STEVENS PHARMACEUTICALS, INC.] | 12 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | DIGOXIN TABLET [JEROME STEVENS PHARMACEUTICALS, INC.] | 12 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | DIGOXIN TABLET [JEROME STEVENS PHARMACEUTICALS, INC.] | 12 | |
| DIGOXIN | ACTIVE INGREDIENT | 73K4184T59 | DIGOX (DIGOXIN) TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| DIGOXIN | ACTIVE MOIETY | 73K4184T59 | DIGOX (DIGOXIN) TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | DIGOX (DIGOXIN) TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | DIGOX (DIGOXIN) TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | DIGOX (DIGOXIN) TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | DIGOX (DIGOXIN) TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | DIGOX (DIGOXIN) TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | DIGOX (DIGOXIN) TABLET [CARILION MATERIALS MANAGEMENT] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50564-545 | DIGOXIN TABLET [JEROME STEVENS PHARMACEUTICALS, INC.] | 13 | Legacy NDC, 2 package rows | 20200123_113fb426-9129-44e7-9d26-b1aa5e10513d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50564-545-01 | 50564054501 | 100 TABLET in 1 BOTTLE (50564-545-01) | 100 tablet | 2002-07-26 | 0000-00-00 | No | No | Current |
| 50564-545-10 | 50564054510 | 1000 TABLET in 1 BOTTLE (50564-545-10) | 1000 tablet | 2002-07-26 | 0000-00-00 | No | No | Current |